CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study was designed to evaluate the safety and efficacy of trastuzumab deruxtecan in HER2-mutated metastatic non-small cell...
Phase 2
Detroit, Michigan, United States and 47 other locations
with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...
Phase 2
Farmington Hills, Michigan, United States and 64 other locations
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Detroit, Michigan, United States and 43 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...
Phase 2
Detroit, Michigan, United States and 83 other locations
, HER3-DXd will be evaluated in participants with metastatic or unresectable NSCLC with EGFR activating mutation or squamous or non-squamous...
Phase 1
Detroit, Michigan, United States and 21 other locations
in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with o...
Phase 3
Detroit, Michigan, United States and 205 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
Farmington Hills, Michigan, United States of America and 123 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
Detroit, Michigan, United States and 122 other locations
previously untreated for advanced or metastatic, PD-L1 positive non-small cell lung cancer (NSCLC). The ...
Phase 2
Sterling Heights, Michigan, United States and 23 other locations
and osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ...
Phase 1
Detroit, Michigan, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal